Literature DB >> 20439754

Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma.

Coen Maas1, Joost C M Meijers, J Arnoud Marquart, Kamran Bakhtiari, Cees Weeterings, Philip G de Groot, Rolf T Urbanus.   

Abstract

The mechanism by which the intrinsic pathway of coagulation contributes to physiological hemostasis is enigmatic. Thrombin activates factor XI, a key zymogen in this pathway, which leads to increased thrombin generation. As thrombin-dependent activation of factor XI in vitro is relatively inefficient, we hypothesized that a physiological cofactor supports this reaction in a plasma environment. We therefore investigated whether the cofactors of coagulation, activated factor V, activated factor VIII, high-molecular weight kininogen, or protein S, influenced activation of factor XI by thrombin. Only activated factor V stimulated activation of factor XI by thrombin in a purified system. Binding studies demonstrated that factor XI specifically interacts with both factor V and factor Va through multiple binding sites. We further investigated this cofactor function of activated factor V in plasma. Depletion of factor V, or the addition of activated protein C, decreased the activation of the intrinsic pathway by thrombin in plasma. However, activated protein C did not exert this effect in the plasma of a homozygous carrier of the prothrombotic factor V Leiden mutation. In conclusion, we propose a role for (activated) factor V as a cofactor in the activation of factor XI by thrombin. These findings offer insights into the coagulation system in both health and disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439754      PMCID: PMC2889092          DOI: 10.1073/pnas.1004741107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein.

Authors:  Thomas Renné; David Gailani; Joost C M Meijers; Werner Müller-Esterl
Journal:  J Biol Chem       Date:  2001-11-30       Impact factor: 5.157

2.  AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER.

Authors:  R G MACFARLANE
Journal:  Nature       Date:  1964-05-02       Impact factor: 49.962

3.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

4.  Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma.

Authors:  V H Donaldson; J Kleniewski; H Saito; J K Sayed
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

Review 5.  Regulation of fibrinolysis by thrombin activatable fibrinolysis inhibitor, an unstable carboxypeptidase B that unites the pathways of coagulation and fibrinolysis.

Authors:  Laurent O Mosnier; Bonno N Bouma
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-07       Impact factor: 8.311

6.  Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

Authors:  P A Von dem Borne; L Bajzar; J C Meijers; M E Nesheim; B N Bouma
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

7.  Factor XI-dependent reciprocal thrombin generation consolidates blood coagulation when tissue factor is not available.

Authors:  Simone J H Wielders; Suzette Béguin; H Coenraad Hemker; Theo Lindhout
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-08       Impact factor: 8.311

8.  Feedback activation of factor XI by thrombin does not occur in plasma.

Authors:  Donna L Pedicord; Dietmar Seiffert; Yuval Blat
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-25       Impact factor: 11.205

9.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Authors:  Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

10.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

View more
  10 in total

1.  PolyP and APC fight a RAGEing battle.

Authors:  Laurent O Mosnier
Journal:  Blood       Date:  2014-02-06       Impact factor: 22.113

2.  Evidence for factor IX-independent roles for factor XIa in blood coagulation.

Authors:  A Matafonov; Q Cheng; Y Geng; I M Verhamme; O Umunakwe; E I Tucker; M-F Sun; V Serebrov; A Gruber; D Gailani
Journal:  J Thromb Haemost       Date:  2013-12       Impact factor: 5.824

3.  Polyphosphate is a cofactor for the activation of factor XI by thrombin.

Authors:  Sharon H Choi; Stephanie A Smith; James H Morrissey
Journal:  Blood       Date:  2011-10-05       Impact factor: 22.113

4.  Activation of factor XI by products of prothrombin activation.

Authors:  Anton Matafonov; Suryakala Sarilla; Mao-fu Sun; John P Sheehan; Vladimir Serebrov; Ingrid M Verhamme; David Gailani
Journal:  Blood       Date:  2011-04-28       Impact factor: 22.113

5.  Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.

Authors:  Jevgenia Zilberman-Rudenko; Asako Itakura; Chantal P Wiesenekker; Ralf Vetter; Coen Maas; David Gailani; Erik I Tucker; András Gruber; Christoph Gerdes; Owen J T McCarty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-01-14       Impact factor: 8.311

6.  New Tools to Study Contact Activation.

Authors:  Steffen Rosén
Journal:  Front Med (Lausanne)       Date:  2016-11-22

7.  Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.

Authors:  Pradeep K Singh; Zu-Lin Chen; Katharina Horn; Erin H Norris
Journal:  Res Pract Thromb Haemost       Date:  2022-10-13

8.  Cryo-EM structures of human coagulation factors V and Va.

Authors:  Eliza A Ruben; Michael J Rau; James A J Fitzpatrick; Enrico Di Cera
Journal:  Blood       Date:  2021-06-03       Impact factor: 25.476

Review 9.  Bradykinin: Inflammatory Product of the Coagulation System.

Authors:  Zonne Hofman; Steven de Maat; C Erik Hack; Coen Maas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 10.  Interplay between platelets and coagulation.

Authors:  Yaqiu Sang; Mark Roest; Bas de Laat; Philip G de Groot; Dana Huskens
Journal:  Blood Rev       Date:  2020-07-12       Impact factor: 10.626

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.